1st Quarter - Report

MERCK & CO, INC. for MERCK & CO INC

Firm
Client
Income
—
Expenses
$2,000,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill); tax base erosion (no specific bill); R&D tax credit (no specific bill).

LobbyistCovered position, as disclosed
ELI JOSEPH —
JEROME MURRAY —
KATIE OPPENHEIM —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Alzheimer's education (no specific bill); 340B (no specific bill); National Diabetes Clinical Care Commission Act (H.R. 1074, S. 539); Eliminating Disparities in Diabetes Prevention, Access and Care Act (H.R. 3322); Hepatitis C education (no specific bill); adult vaccine policies (no specific bill); medication adherence (no specific bill); DISARM (H.R. 4187)

LobbyistCovered position, as disclosed
ROBERT FILIPPONE —
ELI JOSEPH —
JEROME MURRAY —
KATIE OPPENHEIM —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4187 (113th), H.R. 3322 (113th), S. 539 (113th), H.R. 1074 (113th)

Copyright/Patent/Trademark CPT

Patent reform (H.R. 3309, S. 1720 )

LobbyistCovered position, as disclosed
ROBERT FILIPPONE —
ELI JOSEPH —
JEROME MURRAY —
KATIE OPPENHEIM —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1720 (113th), H.R. 3309 (113th)

Animals ANI

education on beta-agonists (no specific bills)

LobbyistCovered position, as disclosed
ERIN POLAK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Trans-Pacific Partnership (no specific bill); biologic data exclusivity (no specific bill); trade promotion authority (no specific bill); treatment of intellectual property in India (no specific bill); Playing Fair on Trade and Innovation Act (HR 3167); additives in beef cattle (no specific bill); trade ajustment assistance (no specific bill); international trade barriers for beta-agonists (no specific bill)

LobbyistCovered position, as disclosed
ROBERT FILIPPONE —
ELI JOSEPH —
JEROME MURRAY —
KATIE OPPENHEIM —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3167 (113th)

Medicare/Medicaid MMM

Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Low Income Subsidy Copays in Part D (no specific bill); Independent Payment Advisory Board (S. 351, H.R. 351); sustainable growth rate (H.R. 4302)

LobbyistCovered position, as disclosed
ROBERT FILIPPONE —
ELI JOSEPH —
JEROME MURRAY —
KATIE OPPENHEIM —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 351 (113th), H.R. 4302 (113th), S. 351 (113th)

Budget/Appropriations BUD

Deficit reduction (no specific bill); ADAP funding (no specific bill); omnibus appropriations...

LobbyistCovered position, as disclosed
ROBERT FILIPPONE —
ELI JOSEPH —
JEROME MURRAY —
KATIE OPPENHEIM —
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.